ArticleScience translational medicine2021

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients.

Pauline P Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.